New ex vivo method to objectively assess insulin spatial subcutaneous dispersion through time during pump basal-rate based administration.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
16 11 2023
Historique:
received: 13 06 2023
accepted: 07 11 2023
medline: 20 11 2023
pubmed: 17 11 2023
entrez: 17 11 2023
Statut: epublish

Résumé

Glycemic variability remains frequent in patients with type 1 diabetes treated with insulin pumps. Heterogeneous spreads of insulin infused by pump in the subcutaneous (SC) tissue are suspected but were barely studied. We propose a new real-time ex-vivo method built by combining high-precision imaging with simultaneous pressure measurements, to obtain a real-time follow-up of insulin subcutaneous propagation. Human skin explants from post-bariatric surgery are imaged in a micro-computed tomography scanner, with optimised parameters to reach one 3D image every 5 min during 3 h of 1UI/h infusion. Pressure inside the tubing is recorded. A new index of dispersion (IoD) is introduced and computed upon the segmented 3D insulin depot per time-step. Infusions were hypodermal in 58.3% among 24 assays, others being intradermal or extradermal. Several minor bubbles and one occlusion were observed. IoD increases with time for all injections. Inter-assay variability is the smallest for hypodermal infusions. Pressure elevations were observed, synchronised with air bubbles arrivals in the tissue. Results encourage the use of this method to compare infusion parameters such as pump model, basal rate, catheter characteristics, infusion site characteristics or patient phenotype.

Identifiants

pubmed: 37973963
doi: 10.1038/s41598-023-46993-1
pii: 10.1038/s41598-023-46993-1
pmc: PMC10654403
doi:

Substances chimiques

Insulin 0
Hypoglycemic Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20052

Informations de copyright

© 2023. The Author(s).

Références

Diabetes Spectr. 2019 Aug;32(3):194-204
pubmed: 31462873
Diabetes Obes Metab. 2022 Nov;24(11):2102-2107
pubmed: 35695037
Diabetes Technol Ther. 2013 Apr;15(4):289-94
pubmed: 23427865
J Diabetes Sci Technol. 2012 Jul 01;6(4):954-64
pubmed: 22920824
Sci Rep. 2017 Aug 29;7(1):9613
pubmed: 28852051
Sci Rep. 2018 Jan 18;8(1):1132
pubmed: 29348570
Sensors (Basel). 2023 Mar 08;23(6):
pubmed: 36991668
Biofabrication. 2021 May 14;13(3):
pubmed: 33910175
Diabetes Care. 2016 Sep;39(9):1486-92
pubmed: 27411698
Obes Surg. 2018 Apr;28(4):1098-1108
pubmed: 29076010
Diabetes Technol Ther. 2020 Jun;22(6):476-483
pubmed: 32069066
Genome Biol. 2008 Jan 21;9(1):R14
pubmed: 18208606
Diabetes Technol Ther. 2013 Jul;15(7):575-9
pubmed: 23650901
J Diabetes Sci Technol. 2013 Jan 01;7(1):227-37
pubmed: 23439181
Nat Rev Endocrinol. 2018 Aug;14(8):464-475
pubmed: 29946127
J Diabetes Sci Technol. 2015 Aug 27;9(6):1282-91
pubmed: 26319228
J Pediatr Endocrinol Metab. 2020 Feb 25;33(2):179-184
pubmed: 31812947
Drug Metab Dispos. 2014 Nov;42(11):1881-9
pubmed: 25100673
Diabetes. 2010 Nov;59(11):2817-25
pubmed: 20713683
Diabetes Ther. 2018 Oct;9(5):1741-1756
pubmed: 30014243
Diabetes Technol Ther. 2019 Oct;21(10):557-565
pubmed: 31335164
Diabetes Care. 2008 Feb;31 Suppl 2:S140-5
pubmed: 18227475
Diabetes Metab. 2021 May;47(3):101206
pubmed: 33152550
BMJ Open Diabetes Res Care. 2019 Dec 8;7(1):e000881
pubmed: 31875136
Phys Med Biol. 2012 Nov 7;57(21):7191-203
pubmed: 23060123
Med Sci (Paris). 2018 May;34(5):424-431
pubmed: 29900845
Diabetes Care. 2021 Jul;44(7):1722-1725
pubmed: 34099517
Diabetes Care. 2010 Sep;33(9):1940-4
pubmed: 20585002
AAPS J. 2012 Sep;14(3):559-70
pubmed: 22619041
Diabetes Technol Ther. 2011 Apr;13(4):435-42
pubmed: 21355718
Diabet Med. 1988 Jul-Aug;5(5):434-40
pubmed: 2970915
Diabetes Technol Ther. 2017 Nov;19(11):641-650
pubmed: 28981324
Diabetes Obes Metab. 2022 Mar;24(3):455-464
pubmed: 34739179
Diabetes Care. 2013 Apr;36(4):780-5
pubmed: 23193211
J Diabetes Sci Technol. 2010 May 01;4(3):750-3
pubmed: 20513344

Auteurs

Pauline Jacquemier (P)

Institut Necker Enfants Malades (INEM), IMMEDIAB Laboratory, Université de Paris Cité, INSERM U1151, Paris, France.
Centre Explor, ALHIST - Air Liquide Healthcare, Bagneux, France.

Yann Retory (Y)

LVL Médical Groupe, Lyon, France.
CIAMS, Univ. Paris-Sud, Université Paris-Saclay, 91405, Orsay Cedex, France.
CIAMS, Université d'Orléans, 45067, Orléans, France.

Clara Virbel-Fleischman (C)

Centre Explor, ALHIST - Air Liquide Healthcare, Bagneux, France.

Alexandra Schmidt (A)

Centre Explor, ALHIST - Air Liquide Healthcare, Bagneux, France.

Agnes Ostertag (A)

Université Paris Cité, Inserm U1132 BIOSCAR, 75010, Paris, France.

Martine Cohen-Solal (M)

Université Paris Cité, Inserm U1132 BIOSCAR, 75010, Paris, France.
Service de Rhumatologie, Lariboisiere Hospital, AP-HP, 75010, Paris, France.

Fawaz Alzaid (F)

Institut Necker Enfants Malades (INEM), IMMEDIAB Laboratory, Université de Paris Cité, INSERM U1151, Paris, France.
Dasman Diabetes Institute, Kuwait City, Kuwait.

Louis Potier (L)

Institut Necker Enfants Malades (INEM), IMMEDIAB Laboratory, Université de Paris Cité, INSERM U1151, Paris, France.
Université Paris Cité, UFR de Médecine, Paris, France.
Department of Diabetology, Endocrinology and Nutrition, Bichat Hospital, APHP, Paris, France.

Jean-Baptiste Julla (JB)

Institut Necker Enfants Malades (INEM), IMMEDIAB Laboratory, Université de Paris Cité, INSERM U1151, Paris, France.
Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie Et de Santé Publique, 75013, Paris, France.
Service of Diabetology, Endocrinology and Nutrition, Federation de Diabetologie, Lariboisiere Hospital, 2 Rue Ambroise Paré, 75010, Paris, AP-HP, France.

Jean-François Gautier (JF)

Institut Necker Enfants Malades (INEM), IMMEDIAB Laboratory, Université de Paris Cité, INSERM U1151, Paris, France.
Université Paris Cité, UFR de Médecine, Paris, France.
Service of Diabetology, Endocrinology and Nutrition, Federation de Diabetologie, Lariboisiere Hospital, 2 Rue Ambroise Paré, 75010, Paris, AP-HP, France.

Nicolas Venteclef (N)

Institut Necker Enfants Malades (INEM), IMMEDIAB Laboratory, Université de Paris Cité, INSERM U1151, Paris, France.

Jean-Pierre Riveline (JP)

Institut Necker Enfants Malades (INEM), IMMEDIAB Laboratory, Université de Paris Cité, INSERM U1151, Paris, France. jeanpierre.riveline@aphp.fr.
Université Paris Cité, UFR de Médecine, Paris, France. jeanpierre.riveline@aphp.fr.
Service of Diabetology, Endocrinology and Nutrition, Federation de Diabetologie, Lariboisiere Hospital, 2 Rue Ambroise Paré, 75010, Paris, AP-HP, France. jeanpierre.riveline@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH